Non-viral gene therapy
Improved osteogenic vector for non-viral gene therapy
... of gene therapy encoding an exogenous gene on a plasmid (Feichtinger et ...alternative, gene therapy allows local and sustained release of growth ...of gene therapy in ...
14
Halting angiogenesis by non viral somatic gene therapy alleviates psoriasis and murine psoriasiform skin lesions
... by non-viral gene ...somatic gene therapy with ...trans- gene detectable by the end of the observation period, albeit expres- sion levels were diminished by approximately 3 logs ...
13
Non viral gene delivery systems for tissue repair and regeneration
... cartilage non-viral gene therapy (Table ...SOX9 gene delivery in hMSCs and induce chondrogenesis ...SOX-9 gene delivery enhanced chondrogenesis in targeted cell populations ...
20
NANO-STRUCTURES FOR NON-VIRAL GENE DELIVERY FOR CANCER THERAPY: A REVIEW
... the gene therapy to identify a malfunctioning gene and supply the patient with proper functioning copies of that ...of gene therapy is to introduce therapeutic material into the ...
7
Gene-Enhanced Personalized Regenerative Medicine for Bone
... local gene therapy in ...vivo gene therapy is safer and more helpful; because genetic manipulations get done outside the ...14 Viral and non-viral vectors can be used in ...
5
THE USE OF VIRAL VECTORS IN GENE TRANSFER THERAPY
... Adeno-asociated viruses (AAV) belong to the genus Dependovirus, part of the family Parvoviridae, AAV is small (20 nm), replication-deficient non-enveloped virus. The genome composes of positive or negative ...
6
Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis
... a viral vector that is associated with a polymer coating via an antibody ...eNOS gene therapy using adenoviral vector embedded in stents for the treatment of ...However, viral vectors have a ...
14
Advanced therapies for the treatment of hemophilia: future perspectives
... cell therapy and gene therapy —based on viral (lentiviral and adeno- associated) vectors with improved transfection efficacy and immunogenic properties, or non-viral vectors— may ...
9
Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule
... complete protease inhibitor cocktail 1 mM PMSF, 10 μg/ml leupeptin/aprotinin and 1 μg/ml pepstatin, and centrifuged for 10 min at 4°C at 3000 rpm. The super- natant was collected, and the protein concentration was ...
16
Gene therapy for the treatment of cystic fibrosis
... available gene transfer agent that could be used in a trial designed to assess clinical ...a non-viral gene transfer system was ...optimal non-viral vector was found to be ...
8
Constitutive and inducible co-expression systems for non-viral osteoinductive gene therapy
... are non-conservative (Chakrabarti and Seidman, 1986) and could lead to the elimination of sequences from the ...potential non-conservative recombination events in the direct (tandem organisation of ...
19
VIRAL BASED GENE THERAPY
... as gene consignment vectors as long as of their high delivery efficiency facing obviously combine along non-dividing cells, that’s the precise properties of ...ex-vivo gene delivery mod critical ...
5
Gene Therapy, Early Promises, Subsequent Problems, and Recent Breakthroughs
... (HIV-1), non-human immunodeficiency (SIV), or feline immunodeficiency ...stable gene transfer tool to various cells like stem ...various viral genetic elements has increased the safety of Lentiviral ...
7
Cationic lipids and investigations into non-viral gene delivery systems
... successful therapy to be developed, sequential dosing strategies are required, hence the inflammatory response would seem a sizeable obstacle to the success of these vectors/^ The death of a patient undergoing ...
267
Mickler, Frauke Martina (2013): Live-cell imaging elucidates cellular interactions of gene nanocarriers for cancer therapy. Dissertation, LMU München: Fakultät für Chemie und Pharmazie
... cancer therapy, examples include Doxil (liposomal doxyrubicin) 225 and Daunoxome (liposomal anthracycline) 226 ...of gene therapies have entered clinical ...for gene therapy based cancer ...
170
Gene Therapy: A New Approach in Modern Medicine
... testing gene therapy ...The gene delivered by AAV vectors is not permanently integrated into the cell genome but often have long-term gene ...multi-purpose gene transfer tool in ...
12
A sight on the current nanoparticle based gene delivery vectors
... ful non-viral gene delivery ...good gene delivery properties especially when incorporated in the colloidal particulate systems ...other viral and non-viral ...in ...
9
Sendai F/HN Viroplexes for Efficient Transfection of Leukemic T Cells
... Purpose: Most chemical transfection reagents are ineffective for the transfection of cells in suspension, such as leukemic cell and stem cell lineages. We developed two different types of viroplexes, cationic Sendai F/HN ...
9
Exploiting cis-Acting Replication Elements To Direct Hepatitis C Virus-Dependent Transgene Expression
... Using HCV minigenome reporter vectors with differently truncated NS5B coding sequences fused upstream of the 3 ⬘ UTR, we found that the 3 ⬘ part of NS5B coding region from nucleotides 9067 to 9371 is required for HCV ...
10
umi-unc-2665.pdf
... of gene expression and constitutive secretion using galanin, the same approach might not necessarily prove successful with NPY or the peptide fragment ...12 viral particles/ml) or AAV-FIB-NPY13-36 (3.0 X 10 ...
180